Shanghai Desano Bio-pharmaceutical

Shanghai Desano Bio-pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and large-scale manufacturing of antiretroviral (ARV) drugs and active pharmaceutical ingredients (APIs). The company is recognized as one of the world's leading suppliers of HIV/AIDS medications, significantly contributing to global health through its involvement in the WHO Prequalification program and the Medicines Patent Pool. Desano's portfolio includes a comprehensive range of ARV therapies, as well as treatments for viral hepatitis and oncology. With multiple state-of-the-art manufacturing sites certified by the US FDA and other international regulatory bodies, the company provides both contract development and manufacturing services (CDMO) and its own branded generic products. Desano continues to expand its global footprint by partnering with major multinational pharmaceutical companies to improve the accessibility of life-saving treatments in low- and middle-income countries.